Pvrig expression is an independent prognostic factor and a new potential target for immunotherapy in hepatocellular carcinoma

HIGHLIGHTS

• who: David Jeremie Birnbaum and collaborators from the Predictive Oncology Laboratory, Labeled Team Ligue Nationale Contre Le Cancer, Centre Recherche en University, Marseilles, France have published the Article: PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma, in the Journal: Cancers 2023, 447 of /2023/
• what: The authors aimed at highlighting the potential of this axis as a new therapeutic option for HCC. The overall objective was to assess their releand clinicopathological data, including survival.
• how: These results showed that regarding the TIGIT/DNAM-1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.